142 related articles for article (PubMed ID: 24390799)
1. Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.
Christodouleas JP; Baumann BC; He J; Hwang WT; Tucker KN; Bekelman JE; Tangen CM; Lerner SP; Guzzo TJ; Malkowicz SB; Herr H
Cancer; 2014 Apr; 120(8):1272-80. PubMed ID: 24390799
[TBL] [Abstract][Full Text] [Related]
2. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
Baumann BC; Guzzo TJ; He J; Vaughn DJ; Keefe SM; Vapiwala N; Deville C; Bekelman JE; Tucker K; Hwang WT; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):363-9. PubMed ID: 22658217
[TBL] [Abstract][Full Text] [Related]
4. Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy.
Moschini M; Shariat SF; Abufaraj M; Foerster B; D Andrea D; Soria F; Dell Oglio P; Mattei A; Montorsi F; Colombo R; Briganti A; Gallina A
Urol Oncol; 2017 Dec; 35(12):672.e1-672.e6. PubMed ID: 28887096
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
Reddy AV; Pariser JJ; Pearce SM; Weichselbaum RR; Smith ND; Steinberg GD; Liauw SL
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1031-9. PubMed ID: 27026309
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients.
Ku JH; Kim M; Jeong CW; Kwak C; Kim HH
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1032-1037. PubMed ID: 25035206
[TBL] [Abstract][Full Text] [Related]
7. Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer.
Baumann BC; He J; Hwang WT; Tucker KN; Bekelman JE; Herr HW; Lerner SP; Guzzo TJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):703-6. PubMed ID: 27020106
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
10. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
11. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
Sonpavde G; Khan MM; Svatek RS; Lee R; Novara G; Tilki D; Lerner SP; Amiel GE; Skinner E; Karakiewicz PI; Bastian PJ; Kassouf W; Fritsche HM; Izawa JI; Ficarra V; Dinney CP; Lotan Y; Fradet Y; Shariat SF
BJU Int; 2011 Sep; 108(5):687-92. PubMed ID: 21087453
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
15. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
16. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
17. Predicting the survival of bladder carcinoma patients treated with radical cystectomy.
Cheng L; Weaver AL; Leibovich BC; Ramnani DM; Neumann RM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Cancer; 2000 May; 88(10):2326-32. PubMed ID: 10820355
[TBL] [Abstract][Full Text] [Related]
18. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
[TBL] [Abstract][Full Text] [Related]
19. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
Hugen CM; Polcari AJ; Fitzgerald MP; Dauw C; Flanigan RC; Quek ML
J Surg Oncol; 2010 Sep; 102(4):334-7. PubMed ID: 20607757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
